tirzepatide in adolescents adolescent obesity trial Efficacy and safety of children and with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 Summary of clinical trials that – Tirzepatide as a Potential Disease-Modifying

doi: 10.1093/nar/gkx1089 105 BranisteVAl-AsmakhMKowalCAnuarFAbbaspourATthMet al

Broaden suppliers and add regional distributors or assess international sources

At Set Point Medical Weight Loss Clinic, we are committed to providing our patients with the most advanced, evidence-based treatments for sustainable weight management

WARNING: This product is intended for Laboratory Research Purposes Only

We prioritize accessibility and ensure the supply and availability of Mounjaro 2.5mg (Tirzepatide) Injection in numerous cities across India

The trial enrolled 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27) and ran for 48 weeks